A Long-term Safety Study of ALKS 9072 (Also Known as ALKS 9070)
NCT01626456
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
478
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
ALKS 9072, Low
DRUG:
ALKS 9072, High
Sponsor
Alkermes, Inc.